These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2026500)

  • 61. Diphosphonate bone scanning agents--current concepts.
    Fogelman I
    Eur J Nucl Med; 1982; 7(11):506-9. PubMed ID: 6217074
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship of 99mTc-MDP uptake to regional osseous circulation in skeletally immature and mature dogs.
    McKinstry P; Schnitzer JE; Light TR; Ogden JA; Hoffer P
    Skeletal Radiol; 1982; 8(2):115-21. PubMed ID: 6213042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate.
    Blake GM; Park-Holohan SJ; Cook GJ; Fogelman I
    Semin Nucl Med; 2001 Jan; 31(1):28-49. PubMed ID: 11200203
    [TBL] [Abstract][Full Text] [Related]  

  • 64. SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy.
    Soundararajan R; Naswa N; Sharma P; Karunanithi S; Nazar AH; Das KJ; Bal C; Malhotra A; Kumar R
    Diagn Interv Radiol; 2013; 19(5):405-10. PubMed ID: 23748034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
    Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    J Korean Med Sci; 1994 Feb; 9(1):29-34. PubMed ID: 8068216
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Radiopharmacological profiles of tracers under pathophysiological conditions. 99mTc-methylene diphosphonate uptake by bone in altered thyroid status.
    Pahuja DN; Noronha OP
    Int J Rad Appl Instrum B; 1988; 15(5):573-6. PubMed ID: 3254880
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased renal parenchymal accumulation of Tc-99m HDP in kidney contusion.
    Salimi Z; Vas W; Tang-Barton P; Suresh P; Carlin B
    Clin Nucl Med; 1984 Oct; 9(10):574-6. PubMed ID: 6488654
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The measurement of 153Sm-EDTMP bone uptake rate and its relationship with therapeutic effect].
    Li L; Liang Z; Deng H; Li Y; Zhang X; Yang X
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):446-8. PubMed ID: 12536590
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake.
    Bach-Gansmo T; Wien TN; Løndalen A; Halvorsen E
    Clin Physiol Funct Imaging; 2016 May; 36(3):237-41. PubMed ID: 25524030
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
    Pauwels EK; Camps JA; Blom J; Hermans J; Kelly JD; Cumming SA; Blackburn GM; Rashid A
    Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
    Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
    J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathophysiological premises to radiotracers for bone metastases.
    Cuccurullo V; Cascini G; Rossi A; Tamburrini O; Rotondo A; Mansi L
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):353-73. PubMed ID: 21738112
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Artifactual focal accumulation of Tc-99m bone imaging tracer in the chest. Technical note (bone imaging artifact).
    Tatum JL; Burke TS; Hirsch JI; Fratkin MJ
    Clin Nucl Med; 1985 Jan; 10(1):16-8. PubMed ID: 3978969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.
    al-Nahhas AM; Jinnouchi S; Anagnostopoulos C; Hirsch W; Heary T; McCready VR
    Eur J Nucl Med; 1995 Feb; 22(2):148-53. PubMed ID: 7758502
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gastric accumulation of bone seeking agent in a patient with advanced gastric cancer.
    Kim DW; Jeong HJ; Park SA; Kim CG
    J Korean Med Sci; 2007 Feb; 22(1):153-5. PubMed ID: 17297271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.